The U.S. Food and Drug Administration (FDA) has issued warning letters to seven companies accused of unlawfully marketing products containing 7-hydroxymitragynine (7-OH), a potent opioid compound ...

A Kansas City company is illegally marketing pills that have opioid-like effects and could face possible action, the U.S. Food and Drug Administration wrote in a warning letter sent Tuesday.

The FDA has issued warnings to seven companies for illegally marketing kratom-based products containing 7-OH, a compound not approved for food or supplements, citing safety concerns and unproven ...

The Stop Gas Station Heroin coalition today commended the U.S. Food and Drug Administration (FDA) for issuing warning letters ...

The warning reflects growing concern over a surge in opioid products marketed to US consumers containing concentrated levels of 7-hydroxymitragynine (7-OH).

By Stephanie Brown HealthDay ReporterTUESDAY, July 15, 2025 (HealthDay News) -- The U.S Food and Drug Administration has ...

“There are no FDA-approved drugs containing 7-OH, and it is illegal to market any drugs containing 7-OH,” the FDA said.

The U.S. Food and Drug Administration sent letters to seven companies that sell opioid alternative products containing ...

The U.S. Food and Drug Administration is bringing attention to an unlawful dietary supplement that is turning up in online purchases and retail outlets.

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...